Allurion Repays Massachusetts Life Sciences Center
MLSC – The Massachusetts Life Sciences Center (MLSC) and Natick-based Allurion Technologies announced that the company, which was awarded a $750,000 Accelerator loan from the MLSC in 2011, has repaid the loan with interest after a successful funding round from private investors.
Number To Know…10
MEDTECH INSIGHT – 10 minutes is the time it takes to prep the non-surgical, ingestible Elipse gastric balloon for obesity treatment. Elipse is developed by Allurion Technologies, which just bagged $19m in new funding.
21 intriguing new ideas and trailblazing people
BOSTON GLOBE – Free college for Boston students, an Alzheimer’s hope, weight loss in an (inflatable) pill, and more.
Lyfebulb and Novo Nordisk A/S announce the ten patient entrepreneur finalists for the Lyfebulb-Novo Nordisk Innovation Award
GLOBE NEWSWIRE – The Award Recognizes Patient Entrepreneurs’ Innovative Efforts and Ideas for Management of Diabetes Using Consumer Products, Medical Devices, or Healthcare Information Technologies
Expanding in Stomachs and in Europe, Allurion Adds $6M for Anti-Obesity Device
XCONOMY BOSTON – Plenty of companies sell pills for weight loss or obesity treatment. None of them are quite like Allurion Technologies.
Allurion offers gastric bypass surgery in a pill
TECHCRUNCH – Just swallow a pill and it expands into a balloon in your stomach so you don’t feel hungry. No gastric bypass, no surgery required. Sounds magical, but Boston-based Allurion has created the only non-invasive gastric balloon for obesity.